Entity Common Stock, Shares Outstanding of IMMUNIC, INC. from 01 Aug 2014 to 20 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
IMMUNIC, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 01 Aug 2014 to 20 Feb 2026.
  • IMMUNIC, INC. Entity Common Stock, Shares Outstanding for the quarter ending 20 Feb 2026 was 130,464,825, a 36% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

IMMUNIC, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 130,464,825 +34,647,289 +36% 20 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 120,284,724 +30,205,708 +34% 07 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 98,650,590 +8,571,574 +9.5% 31 Jul 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 95,817,536 +5,738,520 +6.4% 14 May 2025 10-Q 15 May 2025 2025 Q1
Q3 2024 90,079,016 +44,933,633 +100% 31 Oct 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 90,079,016 +45,483,633 +102% 31 Jul 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 90,079,016 +45,675,178 +103% 02 May 2024 10-Q 08 May 2024 2024 Q1
Q3 2023 45,145,383 +5,883,836 +15% 31 Oct 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 44,595,383 +14,030,388 +46% 28 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 44,403,838 +13,863,455 +45% 02 May 2023 10-Q 11 May 2023 2023 Q1
Q3 2022 39,261,547 +13,012,108 +50% 28 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 30,564,995 +4,315,556 +16% 31 Jul 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 30,540,383 +8,790,944 +40% 02 May 2022 10-Q 10 May 2022 2022 Q1
Q3 2021 26,249,439 +5,531,099 +27% 29 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 26,249,439 +11,281,099 +75% 30 Jul 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 21,749,439 +8,956,099 +70% 03 May 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 20,718,340 +10,601,304 +105% 31 Oct 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 14,968,340 +4,874,886 +48% 31 Jul 2020 10-Q/A 03 Aug 2020 2020 Q2
Q1 2020 12,793,340 -29,576,354 -70% 01 May 2020 10-Q 08 May 2020 2020 Q1
Q3 2019 10,117,036 -32,252,658 -76% 01 Nov 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 10,093,454 -32,275,940 -76% 06 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 42,369,694 +696 +0% 31 Mar 2019 10-Q 10 Apr 2019 2019 Q1
Q3 2018 42,369,694 +162,318 +0.38% 31 Oct 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 42,369,394 +162,018 +0.38% 31 Jul 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 42,368,998 +161,622 +0.38% 30 Apr 2018 10-Q 08 May 2018 2018 Q1
Q3 2017 42,207,376 +10,156,526 +32% 20 Oct 2017 10-Q 25 Oct 2017 2017 Q3
Q2 2017 42,207,376 +10,666,515 +34% 31 Jul 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 42,207,376 +10,962,961 +35% 30 Apr 2017 10-Q 09 May 2017 2017 Q1
Q3 2016 32,050,850 +1,625,164 +5.3% 31 Oct 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 31,540,861 +7,525,100 +31% 31 Jul 2016 10-Q 02 Aug 2016 2016 Q2
Q1 2016 31,244,415 +7,232,102 +30% 30 Apr 2016 10-Q 09 May 2016 2016 Q1
Q3 2015 30,425,686 +6,580,466 +28% 31 Oct 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 24,015,761 +2,225,016 +10% 31 Jul 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 24,012,313 30 Apr 2015 10-Q 12 May 2015 2015 Q1
Q3 2014 23,845,220 07 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 21,790,745 01 Aug 2014 10-Q 07 Aug 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.